Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Medtrum

Explore full profile

Medtrum is a diabetes management medical device developer

Huangpu, ChinaFounded 2008Health Tech & Medtech
Valuation $100–250M Last recorded · 2018
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Medtrum and the history behind them.

About Medtrum

Medtrum Technologies, established in Shanghai in 2008 by Yang Cuijun, is a medical device company focused on developing solutions for diabetes management. The company operates in the global diabetes care market, which is experiencing significant growth due to the rising prevalence of the disease. Medtrum's business model involves the development, manufacturing, and sale of its integrated diabetes management systems to patients and healthcare providers. The firm has secured venture capital funding from investors including Sequoia Capital China and BOC Investment to support its manufacturing and research initiatives.

The company's core offering is the TouchCare® system, which integrates a continuous glucose monitor (CGM) and an insulin patch pump, aiming to create a hybrid closed-loop system, sometimes referred to as an 'artificial pancreas'. This system is designed for individuals with Type 1 and Type 2 diabetes who require insulin therapy. Medtrum's product portfolio includes the Nano Patch Pump and the S9 EasySense CGM system. The Nano is a tubeless, waterproof patch pump available in 200U and 300U reservoir sizes, notable for its small and lightweight design. It can be controlled via a dedicated Personal Diabetes Manager (PDM) or a smartphone application, the EasyPatch App, which is compatible with both iOS and Android devices.

The S9 EasySense CGM features a sensor that can be worn for up to 14 days and provides real-time glucose readings every two minutes without requiring finger-prick calibrations. The system includes a slim, rechargeable transmitter that sends data via Bluetooth to a smart device. The accompanying mobile app provides glucose level monitoring, trend analysis, and customizable alerts for high or low glucose events. Data can also be shared remotely with caregivers and healthcare professionals. The integrated TouchCare Nano System uses an algorithm to automatically adjust basal insulin delivery and administer correction boluses based on the CGM readings, helping to increase the user's Time in Range (TIR).

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
Huangpu, China
Employees
11
Open positions
None listed
Dealroom signal
47.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Personal Health, Diabetes, Wearable, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
b2b

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Dec 2018 $29M $116M Sequoia · BOCG Investment —
SERIES BEquity / VC Jan 2018 $0 — Undisclosed —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Medtrum website traffic

Latest recorded traffic for Medtrum is 14K monthly website visits, up 55.6% over the last three months. Medtrum's team grew 10% over the past year.

Latest monthly visits14K 3-month web change+55.6% 1-year team growth+10%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later2 investors entered at this stage

Other known investors1 additional known investor

  • HSG
Employees 11 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇳🇱 Netherlands100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Medtrum on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Medtrum’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.